Oxaliplatin disrupts nucleolar function through biophysical disintegration

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Platinum-based chemotherapy, including oxaliplatin, is crucial for cancer treatment.
• The precise molecular mechanisms underlying platinum drug cytotoxicity and cancer specificity are not fully understood.

Purpose of the Study:

• To elucidate the molecular basis of oxaliplatin's anti-cancer effects.
• To investigate the impact of oxaliplatin on cellular structures and processes.

Main Methods:

• Utilized biophysical techniques to observe nucleolar behavior.
• Assessed cell-cycle progression and transcription.
• Analyzed platinum compound partitioning within cells.

Main Results:

• Oxaliplatin induces liquid-liquid demixing of nucleoli at therapeutic concentrations.
• This disruption causes cell-cycle arrest and inhibits RNA Polymerase I-mediated transcription.
• Data suggest oxaliplatin targets nucleolar RNA and proteins, not a single molecule.

Conclusions:

• Oxaliplatin's cytotoxicity stems from inducing nucleolar phase separation, a biophysical defect.
• This mechanism offers a novel strategy for targeting cellular processes within biomolecular condensates.
• Understanding nucleolar function is key to developing new anti-cancer therapies.